Novo Nordisk A/S 0QIU.IL Stock
Novo Nordisk A/S Price Chart
Novo Nordisk A/S 0QIU.IL Financial and Trading Overview
| Novo Nordisk A/S stock price | 886.15 DKK |
| Previous Close | 662.3 DKK |
| Open | 0 DKK |
| Bid | 0 DKK x 0 |
| Ask | 0 DKK x 0 |
| Day's Range | 0 - 0 DKK |
| 52 Week Range | 0 - 742.2 DKK |
| Volume | 140 DKK |
| Avg. Volume | 841.42K DKK |
| Market Cap | 2.77T DKK |
| Beta (5Y Monthly) | 0.210466 |
| PE Ratio (TTM) | 44.461643 |
| EPS (TTM) | 14.86 DKK |
| Forward Dividend & Yield | 7.08 (1.04%) |
| Ex-Dividend Date | August 18, 2023 |
| 1y Target Est | N/A |
0QIU.IL Valuation Measures
| Enterprise Value | 3.03T DKK |
| Trailing P/E | 44.461643 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 13.780005 |
| Price/Book (mrq) | 32.732227 |
| Enterprise Value/Revenue | 15.065 |
| Enterprise Value/EBITDA | 32.649 |
Trading Information
Novo Nordisk A/S Stock Price History
| Beta (5Y Monthly) | 0.210466 |
| 52-Week Change | N/A |
| S&P500 52-Week Change | N/A |
| 52 Week High | 742.2 DKK |
| 52 Week Low | 0 DKK |
| 50-Day Moving Average | 688.92 DKK |
| 200-Day Moving Average | 601.61 DKK |
0QIU.IL Share Statistics
| Avg. Volume (3 month) | 841.42K DKK |
| Avg. Daily Volume (10-Days) | 387.22K DKK |
| Shares Outstanding | 3.4B |
| Float | 3.21B |
| Short Ratio | N/A |
| % Held by Insiders | N/A |
| % Held by Institutions | N/A |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 7.075 |
| Trailing Annual Dividend Yield | 1.06% |
| 5 Year Average Dividend Yield | 158.00% |
| Payout Ratio | 0.4165 |
| Last Split Factor | 5:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | June 30, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 33.39% |
| Operating Margin (ttm) | 43.20% |
| Gross Margin | 84.35% |
| EBITDA Margin | 46.14% |
Management Effectiveness
| Return on Assets (ttm) | 21.75% |
| Return on Equity (ttm) | 81.53% |
Income Statement
| Revenue (ttm) | 201.33B DKK |
| Revenue Per Share (ttm) | 44.69 DKK |
| Quarterly Revenue Growth (yoy) | 31.60% |
| Gross Profit (ttm) | 148.51B DKK |
| EBITDA | 92.89B DKK |
| Net Income Avi to Common (ttm) | 67.24B DKK |
| Diluted EPS (ttm) | 14.86 |
| Quarterly Earnings Growth (yoy) | 45.89% |
Balance Sheet
| Total Cash (mrq) | 36.41B DKK |
| Total Cash Per Share (mrq) | 8.11 DKK |
| Total Debt (mrq) | 25.7B DKK |
| Total Debt/Equity (mrq) | 28.41 DKK |
| Current Ratio (mrq) | 0.878 |
| Book Value Per Share (mrq) | 20.185 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 89.73B DKK |
| Levered Free Cash Flow (ttm) | 53.32B DKK |
Profile of Novo Nordisk A/S
| Country | United Kingdom |
| State | N/A |
| City | Bagsvaerd |
| Address | Novo Alle 1 |
| ZIP | 2880 |
| Phone | 45 44 44 88 88 |
| Website | https://www.novonordisk.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 59337 |
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Rare Disease. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, glucagon, needles, and other chronic diseases. The Rare Disease segment offers products in the areas of haemophilia, blood disorders, endocrine disorders, growth disorders, and hormone replacement therapy. The company has a collaboration agreement with Gilead Sciences, Inc.; and research collaboration with Novo Nordisk to discover cell-specific carriers of nucleic acid therapeutics. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark.
Q&A For Novo Nordisk A/S Stock
What is a current 0QIU.IL stock price?
Novo Nordisk A/S 0QIU.IL stock price today per share is 886.15 DKK.
How to purchase Novo Nordisk A/S stock?
You can buy 0QIU.IL shares on the IOB exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Novo Nordisk A/S?
The stock symbol or ticker of Novo Nordisk A/S is 0QIU.IL.
Which industry does the Novo Nordisk A/S company belong to?
The Novo Nordisk A/S industry is Biotechnology.
How many shares does Novo Nordisk A/S have in circulation?
The max supply of Novo Nordisk A/S shares is 4.17B.
What is Novo Nordisk A/S Price to Earnings Ratio (PE Ratio)?
Novo Nordisk A/S PE Ratio is 59.23123000 now.
What was Novo Nordisk A/S earnings per share over the trailing 12 months (TTM)?
Novo Nordisk A/S EPS is 14.86 DKK over the trailing 12 months.
Which sector does the Novo Nordisk A/S company belong to?
The Novo Nordisk A/S sector is Healthcare.